Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Allal Boutajangout
Observed names:
A Boutajangout,
A. Boutajangout,
Boutajangout, Allal
Institution:
New York University
Observed institutions:
Université Libre de Bruxelles,
Vrije Universiteit Brussel,
University of Antwerp,
King Abdulaziz University,
NYU Langone Health,
New York University
show all 6
ORCID:
0000-0002-9582-5675
Observed ORCIDs:
0000-0002-9582-5675,
0000-0003-2405-4292
OpenAlex ID:
A5110141626
Immunotherapy Targeting Pathological Tau Conformers in a Tangle Mouse Model Reduces Brain Pathology with Associated Functional Improvements
2007
·
Ayodeji A. Asuni
, Allal Boutajangout
, et al.
·
Journal of Neuroscience
·
507
PDF
Passive immunization targeting pathological phospho‐tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain
2011
·
Allal Boutajangout
, Johanna Ingadottir
, et al.
·
Journal of Neurochemistry
·
307
PDF
Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model
2010
·
Allal Boutajangout
, David Quartermain
, et al.
·
Journal of Neuroscience
·
272
PDF
The active form of glycogen synthase kinase-3? is associated with granulovacuolar degeneration in neurons in Alzheimer's disease
2002
·
Allal Boutajangout
, Karelle Leroy
, et al.
·
Acta Neuropathologica
·
186
Induction of Toll-Like Receptor 9 Signaling as a Method for Ameliorating Alzheimer's Disease-Related Pathology
2009
·
Henrieta Scholtzova
, Richard J. Kascsak
, et al.
·
Journal of Neuroscience
·
166
PDF
Detection of Amyloid Plaques Targeted by Bifunctional USPIO in Alzheimer’s Disease Transgenic Mice Using Magnetic Resonance Microimaging
2013
·
Youssef Zaim Wadghiri
, Jialin Li
, et al.
·
PLoS ONE
·
114
PDF
Tau-Based Therapeutic Approaches for Alzheimer's Disease - A Mini-Review
2014
·
Allal Boutajangout
, Thomas Wisniewski
·
Gerontology
·
103
Tau as a Therapeutic Target for Alzheimers Disease
2011
·
A. Boutajangout
, E. M. Sigurdsson
, et al.
·
Current Alzheimer Research
·
97
PDF
Vaccination of Alzheimer's model mice with Aβ derivative in alum adjuvant reduces Aβ burden without microhemorrhages
2006
·
Ayodeji A. Asuni
, Allal Boutajangout
, et al.
·
European Journal of Neuroscience
·
91
Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1
2003
·
Allal Boutajangout
, Michèle Authelet
, et al.
·
Neurobiology of Disease
·
88
TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia
2015
·
Stephanie H. Greco
, Lena Tomkötter
, et al.
·
PLoS ONE
·
81
PDF
Expression of tau mRNA and soluble tau isoforms in affected and non‐affected brain areas in Alzheimer's disease
2004
·
A. Boutajangout
, A. Boom
, et al.
·
FEBS Letters
·
77
PDF
The Innate Immune System in Alzheimer’s Disease
2013
·
Allal Boutajangout
, Thomas Wisniewski
·
International Journal of Cell Biology
·
69
PDF
Blocking the apolipoprotein E/Amyloid β interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid β and tau pathology
2013
·
Shan Liu
, Ariel Breitbart
, et al.
·
Journal of Neurochemistry
·
60
The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies
2002
·
D.P Hanger
, G.M Gibb
, et al.
·
FEBS Letters
·
55
PDF
Meloxicam improves object recognition memory and modulates glial activation after splenectomy in mice
2012
·
Angela R. Kamer
, Samuel M. Galoyan
, et al.
·
European Journal of Anaesthesiology
·
54
Vaccination as a Therapeutic Approach to Alzheimer's Disease
2010
·
Thomas Wisniewski
, Allal Boutajangout
·
Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine
·
51
PDF
Increased tau phosphorylation but absence of formation of neurofibrillary tangles in mice double transgenic for human tau and Alzheimer mutant (M146L) presenilin-1
2002
·
A. Boutajangout
, K. Leroy
, et al.
·
Neuroscience Letters
·
40
Immunotherapeutic approaches for Alzheimer’s disease in transgenic mouse models
2009
·
Thomas Wisniewski
, Allal Boutajangout
·
Brain Structure and Function
·
38
Amyloid beta immunization worsens iron deposits in the choroid plexus and cerebral microbleeds
2013
·
Nelly Joseph-Mathurin
, Olène Dorieux
, et al.
·
Neurobiology of Aging
·
37
Assessing the binding of cholinesterase inhibitors by docking and molecular dynamics studies
2017
·
M. Rejwan Ali
, Mostafa Sadoqi
, et al.
·
Journal of Molecular Graphics and Modelling
·
34
Human Umbilical Cord Stem Cell Xenografts Improve Cognitive Decline and Reduce the Amyloid Burden in a Mouse Model of Alzheimer's Disease
2016
·
Allal Boutajangout
, Abdulwahab Noorwali
, et al.
·
Current Alzheimer Research
·
31
Inhaled nitric oxide improves short term memory and reduces the inflammatory reaction in a mouse model of mild traumatic brain injury
2013
·
Ping Liu
, Yong-sheng Li
, et al.
·
Brain Research
·
27
Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer’s Disease Mouse Model
2019
·
Allal Boutajangout
, Hanna Lindberg
, et al.
·
Frontiers in Aging Neuroscience
·
25
PDF
Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer’s disease model
2018
·
Fernando Goñi
, Mitchell Martá-Ariza
, et al.
·
Alzheimer s Research & Therapy
·
20
Show more works
View as search
Works count:
97
Citation count:
2,766
H-index:
24
I10-index:
29
Year
Topic
Type
